As it continues to launch its first cardiovascular product, NitroMed Inc. raised gross proceeds of $62.5 million in a private placement of common stock. (BioWorld Today) Read More
Metabolon Inc., a low-key company specializing in biomarkers for drugs and diagnostics, raised $8 million in a Series B funding round that closed last week. Read More
